{"id":25871,"date":"2023-10-05T08:20:00","date_gmt":"2023-10-05T02:50:00","guid":{"rendered":"https:\/\/blog.researchandranking.com\/?p=25871"},"modified":"2025-11-10T13:31:37","modified_gmt":"2025-11-10T08:01:37","slug":"upcoming-ipos-in-october-2023","status":"publish","type":"post","link":"https:\/\/www.equentis.com\/blog\/upcoming-ipos-in-october-2023\/","title":{"rendered":"Upcoming IPOs in October 2023"},"content":{"rendered":"<div id=\"bsf_rt_marker\"><\/div><div class=\"wp-block-post-date\"><time datetime=\"2023-10-05T08:20:00+05:30\">October 5, 2023<\/time><\/div>\n\n\n<p><\/p>\n\n\n\n<p>In the dynamic world of finance, staying ahead of the game is paramount. After a bustling September with over 10 mainboard IPOs, October is gearing up to offer more enticing investment opportunities. <\/p>\n\n\n\n<p>This article aims to share a peek into the <a href=\"https:\/\/www.equentis.com\/blog\/upcoming-ipos-to-watch-out-for-in-january-2025\/\">upcoming IPOs<\/a> in October 2023 that can help you make informed decisions and manage your finances judiciously.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Upcoming IPOs in October 2023<\/h2>\n\n\n\n<h3 class=\"wp-block-heading\">1. Tata Technologies: Engineering the Future<\/h3>\n\n\n\n<p>A prominent player in the automotive design sector under the Tata Motors umbrella, <a href=\"https:\/\/www.equentis.com\/blog\/tata-tech-ipo\/\" data-type=\"link\" data-id=\"https:\/\/www.equentis.com\/blog\/tata-tech-ipo\/\">Tata Technologies<\/a> Limited offers a wide array of engineering, research, and development services globally. With a presence in 27 countries, the company&#8217;s <a class=\"wpil_keyword_link\" href=\"https:\/\/www.equentis.com\/ipos\" title=\"IPO\" link=\"linked\" id=\"255\">IPO<\/a> details, including date and price band, are eagerly awaited. To learn more, check the <a href=\"https:\/\/www.sebi.gov.in\/filings\/public-issues\/mar-2023\/tata-technologies-limited_68881.html\" data-type=\"link\" data-id=\"https:\/\/www.sebi.gov.in\/filings\/public-issues\/mar-2023\/tata-technologies-limited_68881.html\" target=\"_blank\" rel=\"noopener\">DRHP<\/a> and the <a href=\"https:\/\/www.moneycontrol.com\/live-index\/sp500?symbol=SPX:IND\" data-type=\"link\" data-id=\"https:\/\/www.moneycontrol.com\/live-index\/sp500?symbol=SPX:IND\" target=\"_blank\" rel=\"noopener\">addendum filed on 3rd October 2023<\/a>. <\/p>\n\n\n\n<h3 class=\"wp-block-heading\">2. EbixCash Limited: Redefining Digital Solutions<\/h3>\n\n\n\n<p>Based in Noida, EbixCash Limited is a technology-driven entity excelling in digital products and services across B2C, B2B, and fintech domains. With a strong foothold in payment solutions, travel, financial technology, and BPO services, <a href=\"https:\/\/www.equentis.com\/blog\/ebix-ipo\/\" data-type=\"link\" data-id=\"https:\/\/www.equentis.com\/blog\/ebix-ipo\/\">EbixCash <\/a>is poised to make a significant impact. <\/p>\n\n\n\n<p>The <a class=\"wpil_keyword_link\" href=\"https:\/\/www.equentis.com\/ipos\" title=\"IPO\" link=\"linked\" id=\"323\">IPO<\/a> is projected to be approximately \u20b96,000 crore, making it one of the most substantial offerings in recent times. Investors intrigued by the fintech and digital sectors might find this <a class=\"wpil_keyword_link\" href=\"https:\/\/www.equentis.com\/ipos\" title=\"IPO\" link=\"linked\" id=\"600\">IPO<\/a> particularly enticing. However, specifics regarding the <a class=\"wpil_keyword_link\" href=\"https:\/\/www.equentis.com\/ipos\" title=\"IPO\" link=\"linked\" id=\"843\">IPO<\/a>, such as the price band and dates, are yet to be announced. Check the DRHP <a href=\"https:\/\/www.sebi.gov.in\/filings\/public-issues\/mar-2022\/ebixcash-limited_56719.html\" data-type=\"link\" data-id=\"https:\/\/www.sebi.gov.in\/filings\/public-issues\/mar-2022\/ebixcash-limited_56719.html\" target=\"_blank\" rel=\"noopener\">here<\/a>. <\/p>\n\n\n\n<h3 class=\"wp-block-heading\">3. Balaji Specialty Chemicals<\/h3>\n\n\n\n<p>Balaji Specialty Chemicals, established in 2010, is a Balaji Amines Limited (BAL) subsidiary. Renowned for manufacturing ethylamine, methylamines, pharma excipients, and specialty chemical derivatives, this company plays a pivotal role in various industries, including pharmaceuticals and agrochemicals. <\/p>\n\n\n\n<p>Headquartered in Solapur, Maharashtra, Balaji Specialty Chemicals Limited is expected to launch its <a class=\"wpil_keyword_link\" href=\"https:\/\/www.equentis.com\/researchandranking\/ipos\" title=\"IPO\" data-wpil-keyword-link=\"linked\" data-wpil-monitor-id=\"974\">IPO<\/a> with an estimated size of ~\u20b9425 crore. <\/p>\n\n\n\n<p>The company&#8217;s client list includes Nanjing Union Chemical Company Limited, Korea India Limited, UPL Limited, Dr. Reddy&#8217;s Laboratories Limited, and Aarti Drugs Limited. To learn more, check the <a href=\"https:\/\/www.sebi.gov.in\/filings\/public-issues\/aug-2022\/balaji-speciality-chemicals-limited-drhp_61929.html\" data-type=\"link\" data-id=\"https:\/\/www.sebi.gov.in\/filings\/public-issues\/aug-2022\/balaji-speciality-chemicals-limited-drhp_61929.html\" target=\"_blank\" rel=\"noopener\">DRHP<\/a>. <\/p>\n\n\n\n<h3 class=\"wp-block-heading\">4. SPC Lifesciences<\/h3>\n\n\n\n<p>Established in 2005 in Gujarat, SPC Lifesciences has made significant strides in the integrated chemical sector. Specializing in basic and advanced intermediates, custom APIs, and key starting materials, the company is set to launch its IPO with an anticipated size of around \u20b9300 crores. Check out the <a href=\"https:\/\/www.sebi.gov.in\/filings\/public-issues\/mar-2023\/spc-life-sciences-limited-drhp_69567.html\" data-type=\"link\" data-id=\"https:\/\/www.sebi.gov.in\/filings\/public-issues\/mar-2023\/spc-life-sciences-limited-drhp_69567.html\" target=\"_blank\" rel=\"noopener\">DRHP<\/a>. <\/p>\n\n\n\n<h3 class=\"wp-block-heading\">The Significance of IPOs<\/h3>\n\n\n\n<p>IPOs are instrumental for both investors and company proprietors. For investors, they present a unique opportunity to get in on the ground floor of a potentially promising company, potentially reaping significant returns as it flourishes. Simultaneously, for company owners, IPOs provide access to substantial capital infusion, enabling expansion, debt reduction, and more. Additionally, they enhance the company\u2019s visibility and credibility, making it an attractive prospect for future funding and partnerships.<\/p>\n\n\n\n<p>As October ushers in a fresh wave of IPOs, astute investors are poised to capitalize on these exciting opportunities. Each company brings its unique value proposition, spanning diverse chemical and technology sectors. <\/p>\n\n\n\n<p>Stay tuned for further updates on IPO dates and price bands. Conduct your due diligence and consult financial experts before making investment decisions.<\/p>\n\n\n\n<p class=\"has-ast-global-color-5-color has-text-color has-background has-link-color wp-elements-99316fa911e3b5ca7f1cfd997eb788c4\" style=\"background-color:#001e5a\"><strong>Know more about:<br><a href=\"https:\/\/www.equentis.com\/ipos\">IPOs<\/a>&nbsp;|&nbsp;<a href=\"https:\/\/www.equentis.com\/ipos\/current-new-ipos\">Current IPOs<\/a><a href=\"https:\/\/www.equentis.com\/ipos\/current-new-ipos\">&nbsp;<\/a>|&nbsp;<a href=\"https:\/\/www.equentis.com\/ipos\/upcoming-ipos\">Upcoming IPOs <\/a>|&nbsp;<a href=\"https:\/\/www.equentis.com\/ipos\/listed-ipos\">Listed IPO<\/a>s | <a href=\"https:\/\/www.equentis.com\/ipos\/closed-ipos\">Closed IPOs<\/a> | <a data-wpil=\"url\" href=\"https:\/\/www.equentis.com\/ipos\/ipo-performers\">IPO Performers<\/a><\/strong><\/p>\n\n\n\n<p class=\"has-ast-global-color-5-color has-vivid-red-background-color has-text-color has-background\">*Disclaimer Note: The securities quoted, if any, are for illustration only and are not recommendatory. This article is for education purposes only and shall not be considered as recommendation or investment advice by&nbsp;Research &amp; Ranking. We will not be liable for any losses that may occur. Investment in securities market are subject to market risks. Read all the related documents carefully before investing. Registration granted by <a href=\"https:\/\/www.equentis.com\/blog\/sebi-registered-investment-advisor-meaning-eligibility\/\">SEBI<\/a>, membership of BASL, and certification from NISM in no way guarantee the performance of the intermediary or provide any assurance of returns to investors.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">FAQs<\/h2>\n\n\n<div class=\"saswp-faq-block-section\"><ol style=\"list-style-type:none\"><li style=\"list-style-type: none\"><h5 class=\"saswp-faq-question-title \"><strong>What factors should I consider before investing in an IPO?<\/strong><\/h5><p class=\"saswp-faq-answer-text\">Factors like the company&#8217;s financial health, industry trends, competition, and overall <a href=\"https:\/\/www.equentis.com\/blog\/what-is-market-sentiment-how-to-analyse-it\/\">market sentiment<\/a> should be evaluated before investing in an IPO.<\/p><li style=\"list-style-type: none\"><h5 class=\"saswp-faq-question-title \"><strong>How can I participate in an IPO?<\/strong><\/h5><p class=\"saswp-faq-answer-text\">Investors can participate in an IPO through a brokerage account. You must place an order with your chosen broker during the IPO&#8217;s subscription period. You can also check this <a href=\"https:\/\/www.equentis.com\/blog\/how-to-buy-ipo\/\" data-type=\"link\" data-id=\"https:\/\/www.equentis.com\/blog\/how-to-buy-ipo\/\">article<\/a> to understand the process better. <\/p><\/ul><\/div>","protected":false},"excerpt":{"rendered":"<p>After a bustling September with over 10 mainboard IPOs, October is gearing up to offer more enticing investment opportunities. <\/p>\n","protected":false},"author":5,"featured_media":25924,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[9],"tags":[],"class_list":["post-25871","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-investing"],"_links":{"self":[{"href":"https:\/\/www.equentis.com\/blog\/wp-json\/wp\/v2\/posts\/25871","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.equentis.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.equentis.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.equentis.com\/blog\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/www.equentis.com\/blog\/wp-json\/wp\/v2\/comments?post=25871"}],"version-history":[{"count":15,"href":"https:\/\/www.equentis.com\/blog\/wp-json\/wp\/v2\/posts\/25871\/revisions"}],"predecessor-version":[{"id":63077,"href":"https:\/\/www.equentis.com\/blog\/wp-json\/wp\/v2\/posts\/25871\/revisions\/63077"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.equentis.com\/blog\/wp-json\/wp\/v2\/media\/25924"}],"wp:attachment":[{"href":"https:\/\/www.equentis.com\/blog\/wp-json\/wp\/v2\/media?parent=25871"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.equentis.com\/blog\/wp-json\/wp\/v2\/categories?post=25871"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.equentis.com\/blog\/wp-json\/wp\/v2\/tags?post=25871"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}